Clincosm LogoSign in Get a demo

SCORE_COTYLE: Postoperative Score Predictive of the Prognosis of Acetabular Fractures

Sponsor
Groupe Hospitalier Paris Saint Joseph (Other)
Overall Status
Recruiting
CT.gov ID
NCT04626388
Collaborator
(none)
300
Enrollment
1
Location
36.7
Anticipated Duration (Months)
8.2
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Acetal fractures are joint fractures that occur in the hip. These fractures affect the functional prognosis of the hip in the short, medium and long term. In the acetabulum fractures operated on, there is a radiological score in the literature allowing the prognosis to be predicted depending on the quality of the postoperative reduction. This score is based on the quality of postoperative reduction assessed on pelvic radios. In addition, the thresholds for poor / good results were determined empirically.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    300 participants
    Observational Model:
    Cohort
    Time Perspective:
    Retrospective
    Official Title:
    Postoperative Score Predictive of the Prognosis of Acetabular Fractures
    Actual Study Start Date :
    Dec 9, 2020
    Anticipated Primary Completion Date :
    Dec 9, 2022
    Anticipated Study Completion Date :
    Dec 31, 2023

    Outcome Measures

    Primary Outcome Measures

    1. Total hip replacement [Year 2]

      This ouctome corresponds to the total hip prosthesis.

    Secondary Outcome Measures

    1. Post-operative complications [Year 2]

      This ouctome corresponds to the postoperative complication rate.

    2. Delay of total hip replacement [Year 2]

      This ouctome corresponds to the delay of total hip replacement.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Inclusion Criteria:

    • Patient whose age is ≥ 18 years

    • Patient operated on for an acetabular fracture at the GHPSJ between January 2004 and December 2014

    • Patient with a minimum postoperative follow-up of 2 years

    • French-speaking patient

    Exclusion Criteria:

    • Patient treated conservatively.

    • Patient under guardianship or curatorship

    • Patient deprived of liberty

    • Patient under legal protection

    • Patient objecting to the use of his medical data as part of this study

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Groupe Hospitalier Paris Saint-Joseph Paris France 75014

    Sponsors and Collaborators

    • Groupe Hospitalier Paris Saint Joseph

    Investigators

    • Principal Investigator: Elias MELHEM, MD, Groupe Hospitalier Paris Saint Joseph

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Groupe Hospitalier Paris Saint Joseph
    ClinicalTrials.gov Identifier:
    NCT04626388
    Other Study ID Numbers:
    • SCORE_COTYLE
    First Posted:
    Nov 12, 2020
    Last Update Posted:
    Jan 21, 2022
    Last Verified:
    Jan 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:
    Fractures, Bone

    Study Results

    No Results Posted as of Jan 21, 2022